Stevens-Johnson syndrome (SJS) is not curable in the traditional sense, but it is survivable and treatable. There is no medication that reverses the reaction once it starts. Instead, treatment focuses on stopping the trigger, supporting the body through the acute phase, and managing complications as the skin heals. Most people survive SJS when it is caught early. Skin typically regrows within three weeks, though long-term effects on the eyes, lungs, and mental health can persist for months or years.
Why SJS Happens in the First Place
SJS is an immune system overreaction, almost always triggered by a medication. Your immune cells misidentify the drug as a threat and launch a massive attack against your own skin cells. Specifically, a type of white blood cell recognizes the drug bound to skin cells and releases a cascade of destructive proteins that punch holes in cell membranes and trigger cell death. This kills the outer layer of skin from within, causing it to blister and peel away from the body.
The medications most commonly linked to SJS account for a surprisingly narrow set of drug classes. Anti-seizure medications are the single largest category, responsible for nearly 18% of reported cases. Lamotrigine alone accounts for about 9% of all cases. Painkillers like acetaminophen and ibuprofen make up the second-largest group at roughly 12.5%. Antibiotics, particularly the combination of sulfamethoxazole and trimethoprim, account for about 8.5%. The gout medication allopurinol is another well-known trigger.
What Acute Treatment Looks Like
The single most important step is immediately stopping the drug that caused the reaction. Every hour of continued exposure worsens the outcome. Beyond that, there is no drug that “cures” SJS. Treatment is supportive, similar to burn care, and often takes place in a burn unit or intensive care unit.
Patients need careful fluid replacement to compensate for the massive fluid loss through damaged skin. The room is kept warm, between 31°C and 32°C (about 88–90°F), because exposed tissue loses heat rapidly. Denuded skin is covered with specialized dressings, including paraffin gauze or newer options like synthetic skin substitutes and silver-releasing wound dressings. Sterile technique is critical because infection is one of the leading causes of death.
Some centers use corticosteroids in the first 24 to 48 hours, tapered over 7 to 10 days, to dampen the immune response. Cyclosporine, an immune-suppressing drug, has shown promise in stabilizing the skin and stopping further peeling. These treatments aim to limit damage rather than reverse it. Early referral to an eye specialist is also standard, since the eyes are frequently affected and early care can prevent scarring.
How Dangerous It Is
Severity varies enormously. Doctors use a scoring system called SCORTEN that predicts mortality based on factors like age, heart rate, cancer history, and the percentage of skin affected. For patients with the lowest scores (0 or 1 risk factors), the mortality rate is about 3.2%. At the highest scores (5 or more risk factors), mortality exceeds 90%. The more skin that detaches, the more dangerous the condition becomes. When more than 30% of the body surface is affected, the condition is reclassified as toxic epidermal necrolysis (TEN), which carries significantly higher mortality.
The Healing Timeline
Skin peeling typically progresses for five to seven days before reaching a plateau. After that, the skin begins to regrow. Re-epithelialization, the process of new skin forming over raw areas, is generally complete within three weeks. Hospital stays vary depending on severity. Patients with limited skin involvement and low severity scores can sometimes be managed on general wards, while those with extensive peeling or higher risk scores require burn unit or ICU-level care for weeks.
Healing skin often looks different than it did before. Permanent changes in pigmentation, both lighter and darker patches, are common. Scarring can occur, particularly in areas where skin loss was deepest. Chronic itching at healed sites is another frequent complaint that can last well beyond the acute phase.
Long-Term Effects on the Eyes
Eye complications are among the most significant long-term consequences. One study found that while only 11% of patients had obvious eye problems during the initial illness, nearly 90% went on to develop chronic ocular complications afterward. The most common issues involve the surface of the eye: tear film instability, chronic dryness, and a type of surface damage called superficial punctate keratopathy, which was present in over 81% of patients studied.
For most survivors, these complications are mild to moderate and do not threaten vision. However, about 17% of patients in one cohort developed more serious lid complications, including misdirected eyelashes that scratch the cornea and significant corneal scarring. These patients had vision reduced to levels ranging from moderately impaired to counting fingers. The severity of eye damage correlates closely with how badly the eyelids were affected during the acute phase.
Other Lasting Complications
SJS can leave marks on nearly every system it touches. The lungs may develop chronic bronchitis, bronchiectasis (permanent widening of the airways), or obstructive breathing problems. Urogenital complications include scarring, adhesions, and strictures that can affect urinary or reproductive function. These issues sometimes don’t become apparent until weeks or months after hospital discharge.
The psychological toll is substantial and often underestimated. Survivors frequently describe anxiety, flashbacks, obsessive worry about symptoms, depression, and difficulty forming close relationships. In one qualitative study, five out of the participants received a formal PTSD diagnosis, and ten more described symptoms consistent with it. Nightmares, hypervigilance around medications, and cognitive difficulties were common. Some survivors reported that the psychological aftermath was harder to manage than the physical recovery, particularly because they felt unprepared for life after discharge. Relationships suffered too. One survivor’s marriage ended because her partner could not cope with the PTSD she developed.
Mental health support made a measurable difference for those who received it. Survivors who lacked access to counseling or emotional support struggled more with coping and described feeling isolated and anxious long after their skin had healed.
Can It Come Back?
SJS can recur, but it is uncommon. A 10-year population study found that multiple recurrences happened in only 1.4% of cases, with a median time to recurrence of about 315 days. The most important prevention strategy is permanent avoidance of the drug that triggered the reaction. This information needs to be clearly documented in your medical records and shared with every healthcare provider you see, including dentists and pharmacists.
Recurrence with a completely different drug is rare but has been reported. Some people carry genetic markers, particularly certain variants of immune system genes, that make them more susceptible to these reactions across multiple medications. If you’ve had SJS once, any new medication should be approached with awareness of this history.
What Recovery Actually Means
Saying SJS is “not curable” can be misleading if taken to mean the outlook is hopeless. Most people survive, and the acute skin reaction does resolve completely within weeks. What “not curable” really means is that the damage done during the reaction cannot be undone by any drug, the process has to run its course, and some effects may be permanent. Your skin will regrow. Your eyes may need ongoing care. Your lungs and urogenital tract may carry lasting changes. And the emotional recovery often takes longer than the physical one.
The best outcomes come from early recognition, immediate withdrawal of the offending drug, and care in a specialized setting with burn expertise. After discharge, long-term follow-up with ophthalmology, dermatology, pulmonology, and mental health professionals helps catch and manage complications before they worsen.